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Abstract: Celiac disease is a lifelong autoimmune disorder triggered by foods containing gluten,
the storage protein in wheat, rye, and barley. The rapidly escalating number of patients diagnosed
with this disease poses a great challenge to both food industry and authorities to guarantee food
safety for all. Therefore, intensive efforts are being made to establish minimal disease-eliciting doses
of gluten and consequently to improve gluten-free labeling. These efforts depend to a high degree
on the availability of methods capable of detecting the protein in food samples at levels as low as
possible. Current analytical approaches rely on the use of antibodies as selective recognition elements.
With limited sensitivity, these methods exhibit some deficiencies that compromise the accuracy of the
obtained results. Aptamers provide an ideal alternative for designing biosensors for fast and selective
measurement of gluten in foods. This article highlights the challenges in gluten detection, the current
status of the use of aptamers for solving this problem, and what remains to be done to move these
systems into commercial applications.
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1. Rationale for Gluten Detection
Gluten, from the Latin word “glue,” is a complex mixture of storage proteins from grains, which
are used as ingredients in a wide range of foods. The introduction of gluten in our diet occurred
about ten thousand years ago, and only in certain parts of the world. This is a relatively short
period in the human history, and it appears that many individuals did not adapt to processing it
well and did not develop immunological tolerance to it. In fact, celiac disease (CD), a complex
autoimmune disorder with immunological, genetic, and environmental components that is triggered
by the ingestion of gluten, is nowadays a common disease affecting one in every hundred individuals
in Western populations [1]. The only effective treatment currently available for these patients is a strict,
life-long gluten-free diet. Along with CD, there are other gluten-related disorders [2], and a growing
number of consumers consider gluten-free products healthy. As a consequence, the production of
gluten-free foods has a thriving market, with global sales approaching $2.5 billion (US) in 2010 and an
estimated $6.2 billion (US) by 2018 [3].
In order to ensure safety, quality, and fairness of international food trade, the Codex Alimentarius
Commission includes cereals containing gluten in the list of foods and ingredients that shall always
be declared [4], and establishes that gluten level should not exceed 20 mg/kg or 100 mg/kg for
“gluten-free” and “very low gluten content” foods, respectively [5]. Following the Codex Alimentarius
recommendations, many countries, including the European Union, Canada, and USA, adopted these
threshold values in their legislation. Even if these values have proven to be useful in managing the diet
of an important part of celiac patients, there are individuals sensitive to lower gluten intakes. In an
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attempt to protect a larger number of celiac people, the Spanish Federation of CD Patients Associations
(FACE) has its own label that guarantees an amount of gluten below 10 mg/kg (10 ppm).
To assess compliance with labeling legislation and guarantee the safety of these products, several
analytical methods have been developed [6], but, despite major efforts, an accurate quantification of
gluten in a variety of food matrices still represents considerable challenges. In fact, current threshold
values for labeling are limited by the sensitivity of the analytical methods used to verify the compliance.
The lowest gluten content, which is guaranteed by the Spanish label FACE [7] is very close to the
limit of quantification provided by the existing analytical methods, but it is not safe enough for some
celiac patients. Therefore, the analytical chemists’ community has to confront this problem and to
provide extremely sensitive and innovative tools for gluten control in food. Aptamer-based assays
can make spectacular contributions to this problem, even beyond the analytical field. The purpose of
this paper is to provide an up-to-date overview of the state of gluten detection methods, highlighting
major challenges and the recent advances in aptamer-based assays. A global wave of investment in
this new technology will open many opportunities in bioanalytical chemistry.
2. Requirements and Challenges in Gluten Detection
The availability of sensitive and robust analytical methods to quantify gluten in foods is of utmost
importance not only to ensure the well-being of gluten sensitive individuals but also for food control
authorities and the food industry. The success of the measurement relies on three main factors as
illustrated in Figure 1: efficient extraction from both raw and processed foods of the harmful proteins
and peptides, the use of a correct standard representative of gluten proteins for calibration, and the
sensitivity and selectivity of the selected method.
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These three factors are hampered by the structural complexity of gluten. The term gluten
encompasses the storage proteins found in the starchy endosperm of various cereals, viz. wheat,
barley, rye, their hybrids, and possibly oat. This means that it is a mixture of hundred proteins of
intricate composition, which are among the most complex protein networks in nature due to both
their varied composition and size, and the variability caused by genotype, growing conditions, and
technological processes [8]. Gluten proteins are classically divided into two main fractions according to
their solubility in alcohol-water solutions without reduction of disulfide bonds: the soluble prolamins
and the insoluble glutelins. Prolamins receive this name because of their high content in the amino
acids proline and glutamine, and are named as gliadins (wheat), secalins (rye), hordeins (barley), and
avenins (oat), depending on the cereal. Although traditionally only prolamins were considered toxic,
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there is evidence that glutelins can also trigger an immune response. Their proline-rich nature makes
gluten proteins resistant to complete proteolytic degradation by digestive enzymes. Therefore, long
peptide fragments survive in the stomach and small intestine after digestion, and these are the true
precipitating factor in predisposed individuals [9]. Different active peptides have been identified up to
now; their composition, predominated by glutamine and proline, contains hydrophobic amino acid
residues such as phenylalanine, tyrosine, and leucine, with many repetitive units varying in length
and frequency depending on the origin [9]. Targeting this repetitive oligopeptides will allow for a
more accurate assessment of toxicity levels.
Gluten extraction protocols should be unbiased, valid for different matrices, and compatible with
the method used for quantification. Although the most commonly used solvent in gluten extraction
is aqueous alcohol (60% ethanol or 50% propanol) [6], it can only extract the prolamin fraction
from non-processed materials. The calculation of gluten content is in this case performed using the
assumption of a 1:1 ratio between prolamins and glutelins. However, differences in the ratio between
the two gluten components depending on the variety and species of the cereal may lead to important
errors [8]. Food sample processing is another determining factor because it affects the reliability
of results by leading to an underestimation of food toxicity in certain situations. Highly processed
samples have been subjected to thermal and enzymatic transformations in which the proteins are
degraded and hydrolyzed, giving rise to shorter amino acid sequences, which often remain toxic, but
they could circumvent certain gluten control tests. Likewise, the heat treatment undergone by foods
during manufacturing negatively affects the recovery of gluten proteins, as it leads to the formation
of protein aggregates, which are insoluble in the alcohol-water mixtures. Therefore, in thermally
processed samples, additional disaggregating and reducing agents such as guanidine chloride and
β-mercaptoethanol, capable of breaking the interchain S-S bonds of protein and solubilizing gluten,
are necessary. The use of these reagents has led to the extraction solution known as a “cocktail” [10].
However, some quantification assays (immunoassays) are incompatible with the extraction cocktail,
because its components can denature the protein receptor. In order to solve this problem, different
gluten extraction solutions have been studied [11]. Among them, UPEX (universal prolamin and
glutelin extractant solution), containing the reducing agent Tris(2-carboxyethyl)-phosphine and the
disaggregating compound N-lauroylsarcosine [12], seems to be compatible with immunochemical
quantification methods and improves the extraction of native gluten protein as well as the denatured
one. In some particular cases, such as samples with a high amount of fats, additional treatment may be
necessary in order to eliminate interferences from the matrix. In any case, it is necessary to verify the
compatibility of the extraction process with the selected quantification method.
The second general problem to be addressed is the selection of a correct reference material for
calibration. Achieving a standard of gluten has become a tough task, and no certified reference material
is indeed available so far. A mixture of 28 European wheat cultivars prepared by the Working Group
on Prolamin Analysis and Toxicity, the so-called PWG [13], is the most used material for calibration
and validation. Although this is a homogeneous and stable material, it only represents the prolamin
fraction of some cereals, and in some cases the use of incurred materials, albeit very costly to obtain,
are recommended [6].
Generally, the available methods for gluten analysis in foodstuffs can be merged into two
groups: (i) direct ones, sensing immunotoxic proteins and peptides, including immunochemical assays,
immunosensors [14] and mass spectrometry analysis [15]; and (ii) indirect ones, based on the detection
of the DNA of the gluten-containing cereals, genosensors [16] and PCR [17]. Although DNA analysis is
more sensitive than protein analysis, it should be considered as a screening tool to confirm the presence
of gluten, and as a complement of the protein-based methods. Moreover, legislation thresholds are
issued in terms of gluten concentration. A precise correlation between the DNA copy number and
gluten concentration in each matrix would be needed to use DNA-based methods for quantitation
purposes. Mass spectrometry analysis is mainly used for the identification of the protein and peptide
profiles from different cereals, but it is not considered as suitable for routine analysis because it requires
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expensive equipment and expertise [6]. Therefore, enzyme-linked immunosorbent assays (ELISAs)
are currently the method of choice for gluten determination in food. Several antibodies targeting
different fragments of gluten proteins have been obtained [6]. Among them, the monoclonal antibodies,
termed Skerrit [18] raised againstω-gliadins, R5 [19] obtained againstω-secalins, and G12 [20] raised
against a 33-mer peptide from α2-gliadin, are the most commonly used in commercial ELISA kits.
Two different assay formats—sandwich and competitive—are possible. However, methods based on
a sandwich assay, where the target is recognized and sandwiched between two antibodies, are not
suitable for quantifying gluten in hydrolyzed samples because the presence of protein fragments with
more than one binding site is unlikely. This drawback can be overcome by using competitive assays
where target does not require multiple epitopes to be quantified [12]. However, these immunoassays
are in general not fully compatible with the cocktail extraction solution because their components may
denature the protein receptors [21]. Table 1 compiles the main commercial immunoassays for gluten
detection in food, comparing their analytical performance. A non-protein receptor for gliadin would
thus contribute to the improvement of gluten detection methods. Nucleic acid aptamers, obtained by
the in vitro selection process SELEX, are a good alternative.
Table 1. Commercial enzyme-linked immunosorbent assays for gluten detection in food.
Antibody Manufacturer Commercial Name Format L.D. (ppm gluten)
Skerrit
[18]
Neogen Biokits Sandwich 1
BioCheck Gluten Check Sandwich 5
ELISA technologies EZ-Gluten Lateral flow device 10
R5 [19]
Bio Control
Systems TransiaPlateProlamins Sandwich 3




Rida Quick Lateral flow device 5








ELISA Sticks Lateral flow device 3
RomerLab
Agra Quant Sandwich 2
Agra-Strip Lateral flow device 5
3. Selection of Gluten-Binding Aptamers
In-vitro selection of aptamers always yields a variety of sequences of higher affinity than the initial
pool, which promotes the misconception of a sure and successful procedure. Now it is commonplace
that not all targets are equally prone to generate useful aptamers (that is, with an affinity in the low
nM or even pM range), and the SELEX success is quantified by some authors to be less than 30% [22].
Unfortunately, there are no general rules to anticipate this behavior. Gluten is one of those elusive
targets probably due to its hydrophobicity that does not fit well with the hydrophilic nature of nucleic
acids. Though we are aware of several failed SELEX for gluten, we succeeded upon the rational and
very careful selection of the specific target and its immobilization strategy [23].
An immobilization-free interaction was discarded to avoid filter partitioning that is labor-intensive
and prone to unspecific binding. Likewise, the use of gliadin was also rejected because of their
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insolubility in aqueous media and difficult immobilization through a covalent (oriented) bond. The
immunodominant peptide known as 33-mer [9] is an apolar compound that can be dissolved in water
at the concentrations required for SELEX. A recombinant variant with a large spacer of 57 amino acids
and a 6-His-tag tail at C-terminal end was selected for immobilization on Ni2+-nitrilotriacetic acid
magnetic beads (Ni2+-NTA MBs). This presentation is advantageous because the long spacer chain
minimizes the steric hindrance with the surface during interaction and exposes the target to the bulk
solution facilitating the recognition. Negative selections to remove any spacer-binding aptamer are
compulsory and were carried out every three rounds of selection. The binding between Ni2+ and
histidines is strong enough to suffer washing steps but also labile enough to be displaced by a high
concentration of a competitor like imidazole, allowing the easy elution of the aptamer-peptide complex
for subsequent PCR amplification.
The selection buffer was carefully chosen to have a high ionic strength to minimize unspecific
electrostatic interactions if possible when using a mostly apolar target, and 1 µg/mL BSA was added
to avoid unspecific adsorption to the surface. A t-RNA was added as a competitor in a ten-fold
lower concentration than the DNA library or pool in each round. The stringency was progressively
increased by reducing the interaction time from 1 h to 15 min and increasing the washing steps from
2 to 15. The combination of two factors is unusually carried out and could be a relevant factor for the
successful selection.
PCR amplification tends to bias the selection toward sequences with weak secondary structures
that are easier to amplify. Likewise, the higher the number of cycles, the higher the chances to produce
artifacts (mainly primer-dimers) [24]. For those reasons, the number of cycles was kept below 18 cycles.
If the recovery was not high enough to initiate the following round, a new PCR was performed using
15 cycles. In all cases, a biotinylated reverse primer was used to allow the separation of the strands
prior to the next round of selection. The strand separation was performed by amplicon entrapment
on streptavidin-coated magnetic beads and dehybridization in 100 mM NaOH followed by magnetic
separation. The supernatant was neutralized with HCl prior to being diluted in the selection buffer.
This method does not require the purification of amplicons as exonuclease digestion, minimizing the
risks of sequence loss [25].
After ten rounds of selection, a pool of aptamers with significant affinity to the target and
negligible to the solid support and spacer was obtained. This was verified by fluorescent binding
assays on Ni2+-NTA MBs coated by the recombinant 33-mer or the control peptide (the spacer). The
aptamer candidates were obtained from each round pool by PCR amplification using a forward primer
labeled with a fluorophore (6-carboxyfluorescein) and the biotinylated reverse primer.
Sequences from round 10 were cloned, sequenced, and analyzed for sequence homologies. They
were clustered into five families with a diverse degree of homology. Variations of a 12-nt motif were
found in four groups with a GTCT core motif shared by all groups, which is an unusual result that
supports a strong convergence.
Currently, there is another aptamer for gliadin detection, obtained using gliadin as a target for
selection [26]. A close inspection of the winning sequences from both SELEX procedures results in
some common characteristics: a low GC content and the absence of a strong secondary structure, just
the opposite for most aptamers described, indicating that it is not a bias of the procedure but a real
evolution for that type of target. This anti-gliadin aptamer has the highest level of homology to the
anti-peptide Gli-1 aptamer (the most abundant one) within the 12-nt motif. Additional alignments
of 33-mer aptamers to the anti-gliadin aptamer show some minor similarities, with short homology
regions (Figure 2). Interestingly, a 9-nt sequence (CGACGTAGT) is shared with an aptamer that was
unique in our enriched pool.
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Such level of coincidence is striking taking into account the significant differences between both
processes. The gliadin aptamer was evolved using Sigma gliadin as a target instead of the accepted
“reference” material (PWG). Chemical properties of this gliadin are quite different from PWG (e.g., it
cannot be dissolved in alcohol-water mixtures), and it is not representative of wheat genetic variability.
The protein was adsorbed on hydrophobic microtiter plates rendering a denatured target with the
hydrophilic moieties exposed to the solution. The random orientation of the target along with the
lack of negative selections can explain the lack of a consensus sequence among the clones except for
only three of them. The stringency was enhanced only by increasing the number of washing steps.
On the other hand, the selection buffer also contained BSA, t-RNA, and a high salt concentration but
not as high as in our procedure. Eight rounds of selections were finally performed, and SPR was
used for enrichment assessment with gliadin covalently immobilized through amine groups on a
dextran matrix.
4. Aptamer-Based Assays for Gluten Detection
Selecting aptamers as the biomolecular recognition element for developing alternative gluten
detection methods relies on various reasons: (i) they are readily obtained by chemical synthesis in
a cost-effective way and with high reproducibility; (ii) they show affinities comparable to those of
monoclonal antibodies but with higher stability due to their nucleic-acid chemical nature; and (iii) they
can be easily combined with different chemical labels/groups that provide flexibility for adaptation to
different platforms, taking advantage of existing analytical techniques.
Aptamer binding affinity is the main criteria to select the receptor. Hence, the capability to
accurately measure binding interaction is very important and numerous analytical methods have been
used to characterize the anti-gliadin aptamers [27]. Label-free techniques such as Surface Plasmon
Resonance (SPR) spectroscopy and Faradaic Impedance Spectroscopy (FIS) are especially suitable to
evaluate the binding affinity when one of the interacting partners is immobilized. Considering the
homogeneous 33-mer peptide-aptamer interaction, characterized by isothermal titration calorimetry,
as a reference (Figure 3, panel A), a slight decrease in the aptamers affinity was recorded when 33-mer
peptide was anchored to an SPR sensor (Figure 3, panel B). Meanwhile, the PWG-gliadin attachment
onto a solid support enlightened the presence of multiple sites for the aptamer binding within the whole
protein, with a positive cooperative effect (enhanced affinity of a binding site when the neighboring
one is occupied). Cooperativity seems to be the responsible for the hardly affected dissociation constant
(Kd) values for the protein-aptamer interaction (Figure 3, panel C), when comparing with those for the
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33-mer peptide. Conversely, the chemisorption of the oligonucleotide receptor was revealed to be more
deleterious for the subsequent recognition of the 33-mer peptide (Figure 3, panel D). An equivalent
approach trying to specifically capture the whole protein was not efficient. This was attributed to the
remarkable avidity of the protein for the gold surface because of the multiple sulfur atoms within
its structure.
Biosensors 2016, 6, 16 7 of 11 
33-mer peptide (Figure 3, panel D). An equivalent approach trying to specifically capture the whol  
protein was not efficient. This was attributed to the remarkable avidity of th  protein f r the gold 
surface because of the multiple sulfur atoms within its structure. 
 
Figure 3. Schematic of the different methods used for evaluating the aptamer binding affinity and 
comparison of the binding constants obtained for the interaction between aptamers and 33-mer 
peptide or PWG. Constants evaluated by (A) isothermal titration calorimetry (ITC); (B) surface 
plasmon resonance spectroscopy (SPR); (C) ICP-MS; (D) faradaic impedance spectroscopy (FIS);  
(E) chronoamperometry; and (F) fluorescence. 
The minor effect on the affinity recorded when 33-mer peptide was immobilized allowed for a 
study of the influence of the aptamer tagging. When aptamers were labeled with biotin, a 2-fold 
increase in Kd value was measured for Gli1 aptamer, and Gli4 affinity was less affected (Figure 3, 
panel E), while the incorporation of a fluorescein tag was more disturbing. The fluorescein-modified 
aptamer affinity towards the immobilized whole protein was two (Gli1) or even three (Gli4) times 
lower than the ones towards the peptide (Figure 3, panel F). A positive cooperative binding was also 
operating, which probably allowed for the measurement of the perturbed interaction.  
It is also important to emphasize that, despite being in greater proportion in the enriched pool, 
Gli1 aptamer is not the most akin aptamer to the target [23,27]. This seemingly contradictory fact is 
not uncommon and can be attributed to a certain preference in SELEX process for sequences that bind 
the peptide more rapidly, rather than those with a higher binding affinity. This result is reasonable 
because the evolution pressure was exerted not only on strength (rinses) but also on time (kinetics). 
The aptassay designed was judiciously guided by the above-mentioned results [28]. The 33-mer 
peptide was immobilized on magnetic beads to take advantage of the minute impact on the binding 
affinity, and a biotin-tagged aptamer was used because of its superior performance in comparison to 
other markers. A competitive assay format was chosen, where competition between the offending 
target in solution and the attached 33-mer peptide for a limited amount of biotinylated aptamer takes 
place. The captured aptamer onto the sensing phase is electrochemically quantified using a redox 
reporter enzyme, which is inversely related to the gluten content in the sample (Figure 4). 
As expected, higher sensitivity for Gli4 was obtained on account of its greater affinity using PWG 
as a gliadin standard [28]. Specifically, it was possible to detect as little as 0.5 ng·L−1 of PWG using 
Gli4 aptamer and 4.9 ng·L−1 with Gli1 aptamer even when ethanol, the main component of the 
extraction solution, is present. Taking into account the compulsory sample extraction step (1:500 
sample dilution) and a consensus gliadin/gluten ratio of 1:2 [29], the previous detection limits are 
translated into 0.5 and 4.9 ppm of gluten for Gli4 and Gli1 aptamers, respectively. Of note, the former 
is the lowest value achieved so far. 
Figure 3. Schematic of the different methods used for evaluating the aptamer binding affinity and
comparison of the binding constants obtained for the interaction between aptamers and 33-mer
peptide or PWG. Constants evaluated by (A) isothermal titration calorimetry (ITC); (B) surface
plasmon resonance spectroscopy (SPR); (C) ICP-MS; (D) faradaic impedance spectroscopy (FIS);
(E) chronoamperometry; and (F) fluorescence.
The minor effect on the affinity recorded when 33-mer peptide was immobilized allowed for
a study of the influence of the aptamer tagging. When aptamers were labeled with biotin, a 2-fold
increase in Kd value was measured for Gli1 aptamer, and Gli4 affinity was less affected (Figure 3, panel
E), while the incorporation of a fluorescein tag was more disturbing. The fluorescein-modified aptamer
affinity towards the immobilized whole protein was two (Gli1) or even three (Gli4) times lower than
the ones towards the peptide (Figure 3, panel F). A positive cooperative binding was also operating,
which probably allowed for the measurement of the perturbed interaction.
It is also important to emphasize that, despite being in greater proportion in the enriched pool,
Gli1 aptamer is not the most akin aptamer to the target [23,27]. This seemingly contradictory fact is
not uncommon and can be attributed to a certain preference in SELEX process for sequences that bind
the peptide more rapidly, rather than those with a higher binding affinity. This result is reasonable
because the evolution pressure was exerted not only on strength (rinses) but also on time (kinetics).
The aptassay designed was judiciously guided by the above-mentioned results [28]. The 33-mer
peptide was immobilized on magnetic beads to take advantage of the minute impact on the binding
affinity, and a biotin-tagged aptamer was used because of its superior performance in comparison to
other markers. A competitive assay format was chosen, where competition between the offending
target in solution and the attached 33-mer peptide for a limited amount of biotinylated aptamer takes
place. The captured aptamer onto the sensing phase is electrochemically quantified using a redox
reporter enzyme, which is inversely related to the gluten content in the sample (Figure 4).
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eluted and quantified by PCR. The limit of detection was arbitrarily set at 100 ppb of gliadin, even 
though analytical signals from non-toxic cereals are indistinguishable, or even lower (signal-off in the 
way proposed). In addition to the complicated scheme, no direct comparison can be made because the 
equivalence in gluten content is unknown since no treatment protocol for real food samples is proposed.  
Our promising “academic” achievement culminated in an innovative and appealing approach 
to real-world applications [28]. Blind samples of different origins and unknown gluten content, as 
well as samples from interlaboratory tests, were analyzed with both the Gli4-based aptassay (the 
most sensitive to determine non-hydrolyzed gluten) and the Gli1-based aptassay (the choice for 
hydrolyzed samples). The analyses revealed a good correlation with G12-based and R5-based ELISA 
commercial methods. Importantly, there were no false-negative results that could have questioned 
i r 4. t - s ss s f r lia i eter ination in processed foods.
As expected, higher sensitivity for Gli4 was obtained on account of its greater affinity using
PWG as a gliadin standard [28]. Specifically, it was possible to detect as little as 0.5 ng¨ L´1 of PWG
using Gli4 aptamer and 4.9 ng¨ L´1 with Gli1 aptamer even when ethanol, the main component
of the extraction solution, is present. Taking into account the compulsory sa ple extraction step
(1:500 sample dilution) and a consensus gliadin/gluten ratio of 1:2 [29], the previous detection limits
are translated into 0.5 and 4.9 ppm of gluten for Gli4 and Gli1 aptamers, respectively. Of note, the
former is the lowest value achieved so far.
Selectivity studies pointed out that both aptamers, Gli1 and Gli4, recognize wheat, barley, and
rye with similar sensitivity and are insensitive to proteins from rice, corn, and soya, widely used in
gluten-free products due to their harmlessness to celiac patients. The difference lies in the controversial
avenins, which are identified only by Gli4 aptamer, albeit with some lower sensitivity. This means
that a combined assay using two aptamers raised from a single SELEX procedure can become a useful
and easy tool for rapid and cost-effective discrimination between toxic and controversial sources
of gluten. This would provide valuable information for CD patients and their capacity to decide.
It is noteworthy that the method internationally accepted by the Codex Alimentarius Commission
based on R5 antibody (againstω-secalins) cannot detect avenins, while those immunoassays relied
on monoclonal antibodies described against the 33-mer gliadin peptide, G12 and A1, also exhibit a
certain affinity for avenins, even though the 33-mer peptide is not included in their structure [30]. Gli1
aptamer showed superior performance when the 33-mer peptide was used as a calibration standard
due to an unexpected but consistent microscopic aggregation of beads. Therefore, Gli1 aptamer is
recommended for the analysis of hydrolyzed food.
Another competitive aptamer-based assay, involving G33 aptamer against Sigma gliadin, has
been recently developed [26]. In that case, gliadin in solution competes with gliadin bound to a
microtiter plate by a G33 aptamer. The amount of oligonucleotide receptor fixed in the well is then
eluted and quantified by PCR. The limit of detection was arbitrarily set at 100 ppb of gliadin, even
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though analytical signals from non-toxic cereals are indistinguishable, or even lower (signal-off in the
way proposed). In addition to the complicated scheme, no direct comparison can be made because
the equivalence in gluten content is unknown since no treatment protocol for real food samples
is proposed.
Our promising “academic” achievement culminated in an innovative and appealing approach to
real-world applications [28]. Blind samples of different origins and unknown gluten content, as well as
samples from interlaboratory tests, were analyzed with both the Gli4-based aptassay (the most sensitive
to determine non-hydrolyzed gluten) and the Gli1-based aptassay (the choice for hydrolyzed samples).
The analyses revealed a good correlation with G12-based and R5-based ELISA commercial methods.
Importantly, there were no false-negative results that could have questioned the usefulness of our
methods to ensure food security for gluten-sensitive population. The presence of a few “false positives”
when compared with the R5 method points to the higher sensitivity of our aptassay. Likewise, the
aptamer-based methodology proved to be compatible with both extraction protocols, the conventional
one consisting of a separation in 2 M NaCl followed by an extraction in 60% ethanol, and the method
using the cocktail solution containing β-mercaptoethanol and guanidine chloride as reducing and
disaggregating agents, respectively, to break the interchain S–S bonds and to solubilize gluten followed
by an alcoholic extraction. Nonetheless, higher gluten values were systematically recorded when
using the cocktail solution, probably because of a larger yield of extraction. Samples containing fats
pose special challenges, and, surprisingly, using the same ELISA test certain variability in the results
has been reported. This issue still remains with aptassays, meaning that the main challenge lies in
target extraction.
According to Codex Alimentarius, food products with a gluten content of less than 20 ppm can be
labeled as “gluten-free” [5]. The official method, a sandwich-type ELISA based on R5 antibody, has a
limit of detection (LD) of 5 ppm of gluten, while for the same antibody-based competitive assay the LD
is 0.75 ppm of gluten. The most sensitive commercial immunoassay, a competitive ELISA based on G12
antibody and marketed by Biomedal, is able to detect as little as 0.6 ppm of gluten. The competitive
aptassay developed becomes sufficiently sensitive and selective to be applied to the determination of
gluten in foods to assess compliance with labeling legislation and to provide consumers with more
information. The Gli4 aptamer-based method would allow for a noticeable lowering of the threshold
value in the legislation, protecting more effectively the most vulnerable celiac population. Likewise,
the detection limit of the Gli1 aptamer-based assay verifies the compliance with current legislation for
gluten-free food labeling.
5. Outlook
Methods for detecting gluten in foods have developed significantly in the last decade. However,
it is not clear to what extend these methods can ensure the protection of all celiac consumers, taking
into account the variability of the gluten safety threshold among individual patients. Hence, it is
paramount to continue developing analytical methods that are even more sensitive, additionally
meeting the requirements of reliability, accuracy, and low cost. We have described a new kind of
receptor (aptamers) for the gluten-derived harmful proteins or peptides that can successfully face some
of the remaining challenges of gluten detection. The new receptors present high affinity and binding
selectivity. In addition, they can be easily labeled with different reporter molecules at a relatively
low production cost. These attributes make aptamers ideal reagents for the development of chemical
sensors and analytical assays.
As discussed here, aptamer-based assays are a new generation of methods for gluten
quantification. Although still in its infancy, this sensitive technology will undoubtedly continue
to advance. It is reasonable to expect that detailed, comprehensive studies to obtain extensive
molecular-level information about the aptamer-protein and aptamer-peptides interactions could
allow for a better understanding of the structural basis of this highly specific interaction, leading to
new modified aptamers with improved affinity properties. In addition, the combination of aptamers
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with nanomaterials, such as carbon nanotubes, graphene, and metal nanoparticles, either as an
immobilization platform or as label agents, and the adaptation of aptamers to a great variety of
read-out configurations will likely result in sensitive and easy-to-use tools for gluten detection.
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